This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...